| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 27, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 27, 2014-- Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and...
-
Feb 27, 2014- U.S. revenue increased 94% in fourth quarter 2013 to $25.9 million, from $13.4 million in fourth quarter of 2012
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 27, 2014
MINNEAPOLIS - Feb 27, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 34th Annual Healthcare...
-
Feb 26, 2014
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 24, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 24, 2014-- Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3. Charles J....
-
Feb 18, 2014Revenue of $4.2 Billion Grew 4% on a Constant Currency Basis; 3% as Reported
MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...
-
Jan 28, 2014Supported by Recently Presented Study Results, New Indication Expands Treatment Options for Patients with Dangerous Tear in Upper Segment of Body's Main Artery
MINNEAPOLIS -- Jan. 28, 2014 -- Continuing to expand the role of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) has received approval from the U.S. Food and Drug Administration (FDA) for...
-
Jan 27, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese...
-
Jan 27, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire...
-
Jan 24, 2014Net sales up 3% (up 5%, excluding foreign exchange rate movement); Medical Devices sales up 3% (up 6%, excluding foreign exchange rate movement)
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 24, 2014-- Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of